← back to search

Hironaga Satake

Aichi Cancer Center · JP
Area of research
Oncology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Colorectal Cancer Treatments and Studies, Gastric Cancer Management and Outcomes, Cancer Treatment and Pharmacology, and Lung Cancer Treatments and Mutations.
h-index
24
citations
3,563
works
302
NIH funding
—
primary concept
Medicine
email
takeh1977@gmail.com

Recent publications

Sotorasib in <i>KRAS</i> p.G12C–Mutated Advanced Pancreatic Cancer
New England Journal of Medicine 2022cited by 454position: middledoi
First data for sotorasib in patients with pancreatic cancer with <i>KRAS</i> p.G12C mutation: A phase I/II study evaluating efficacy and safety
Journal of Clinical Oncology 2022cited by 43position: middledoi
Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer
JAMA Oncology 2020cited by 1,117position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Andrew L. Coveler · University of Washington School of Medicine2 papers (2022–2022)Gerald S. Falchook · Sarah Cannon Research Institute2 papers (2022–2022)David L. Bajor · University Hospitals of Cleveland2 papers (2022–2022)Antoine Hollebecque · Institut Gustave Roussy2 papers (2022–2022)Dejan Juric · Harvard University2 papers (2022–2022)Mark Vincent · Western University2 papers (2022–2022)Pegah Jafarinasabian · AbbVie (United States)2 papers (2022–2022)John H. Strickler · Cancer Institute (WIA)2 papers (2022–2022)Yu Sunakawa · Japanese Foundation For Cancer Research2 papers (2022–2022)Thomas J. George · University of Florida Health2 papers (2022–2022)Qui Tran · University of Tartu2 papers (2022–2022)Sun Young Rha · Incheon Medical Center2 papers (2022–2022)David S. Hong · The University of Texas MD Anderson Cancer Center2 papers (2022–2022)Charlotte Lemech · BioScientia (Poland)2 papers (2022–2022)Ignacio Garrido‐Laguna · University of Utah2 papers (2022–2022)Martin Schüler · National Center for Tumor Diseases2 papers (2022–2022)Rona Yaeger · Memorial Hospital2 papers (2022–2022)Timothy F. Burns · Mayo Clinic in Arizona2 papers (2022–2022)Pascale Tomasini · Centre de Recherche en Cancérologie de Marseille1 papers (2022–2022)Gataree Ngarmchamnanrith · Arsenal Biosciences (United States)1 papers (2022–2022)